Study Stopped
Unable to conduct study because of political issues in host country.
Ability of Bedside Ultrasound to Predict Progression of Severity of Disease in Dengue Fever
1 other identifier
observational
N/A
1 country
1
Brief Summary
The purpose of this study is determine the ability of bedide ultrasound performed in the Emergency Department and Outpatient Department can predict the severity of disease during a Dengue Fever outbreak in children, in Siem Reap, Cambodia. Our hypothesis is that the presence of gallbladder wall thickening and/or pleural effusions in children correlates with progression to Dengue hemorrhagic fever and Dengue shock. In addition, we hypothesize that sonographic imaging of pediatric patients presenting to the emergency department with a fever during a Dengue fever outbreak will change management and disposition.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jan 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 29, 2014
CompletedFirst Posted
Study publicly available on registry
May 9, 2014
CompletedStudy Start
First participant enrolled
January 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2016
CompletedJune 11, 2015
June 1, 2015
1.4 years
April 29, 2014
June 10, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Progression of Disease
Changes in clinical course or progression of disease in patients with Dengue Fever or Dengue Hemorrhagic Fever
Patients who are discharged from home will be contacted a maximum of 10 days after discharge to acquire follow up data. Those patients who are admitted to the hospital will monitored for the entirety of their hospital stay, an average of about 2 weeks.
Secondary Outcomes (1)
Clinical Care
Patients will receive an ultrasound in the emergency department or outpatient department. Within 2 hours of study enrollment, the treating physician will be made aware of the test results and will be queried for changes in decision making.
Other Outcomes (1)
Disposition
Patients will receive an ultrasound in the emergency department or outpatient department. Within 2 hours of study enrollment, the treating physician will be made aware of the test results and will be queried for decision to admit versus discharge.
Study Arms (1)
Suspected Dengue
Children with an acute febrile illness, and two of the following: headache, retro-orbital pain, myalgias, arthralgia, rash, hemorrhagic manifestations, or plasma leakage (i.e. shortness of breath, abdominal distention/pain) will all receive a diagnostic bedside ultrasound.
Interventions
Patients enrolled in this study will undergo bedside ultrasound during their initial presentation to the emergency department. Ultrasound imaging protocols include the following: * FAST Exam - Standard images will be obtained using the abdominal transducer. Images include the following: 1) sub-xyphoid 2)right upper quadrant (with right thorax) 3)left upper quadrant (with left thorax) and 4) suprapubic * Right Upper Quadrant Exam - Standard images will be obtained using the abdominal transducer. Images include the following: 1) Long axis of the gallbladder 2) Transverse axis of the gallbladder fundus 3) Transverse axis of the gallbladder body and 4) Transverse axis of the gallbladder neck.
Eligibility Criteria
Study subjects will include children 16 years or less, who present during the annual Dengue Fever outbreak with suspected Dengue fever. Subjects include children with an acute febrile illness, and two of the following: headache, retro-orbital pain, myalgias, arthralgia, rash, hemorrhagic manifestations, or plasma leakage (i.e. shortness of breath, abdominal distention/pain)
You may qualify if:
- Age \>3 months and \<16 years
- Clinical suspicion of dengue hemorrhagic fever. (Revised WHO Classification System)
- Not a prisoner or ward of the state
- Parents able and willing to give consent. Children older then 7 able and willing to give assent
You may not qualify if:
- Allergic to Ultrasound gel
- Prisoners or wards of the state
- Unstable patients
- Known pleural effusion, ascites, or gallbladder wall thickening.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Angkor Hospital for Children
Siem Reap, Cambodia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Samuel D Licciardo, M.D.
University of Massachusetts, Worcester
- STUDY CHAIR
Romolo Gaspari, M.D., Ph.D.
University of Massachusetts, Worcester
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 29, 2014
First Posted
May 9, 2014
Study Start
January 1, 2015
Primary Completion
June 1, 2016
Study Completion
June 1, 2016
Last Updated
June 11, 2015
Record last verified: 2015-06